Showing results (51-60 of 4,972) with videos related to

Sort By:
Pageof 498
The Journal of Urology|April 1, 1996
Protective effect of Tadenan on bladder function secondary to partial outlet obstructionR M Levin, J P Riffaud, F Bellamy, et al.
The Journal of Urology|December 1, 1996
Effects of tadenan pretreatment on bladder physiology and biochemistry following partial outlet obstructionR M Levin, J P Riffaud, F Bellamy, et al.
The Urologic Clinics of North America|May 1, 1997
Reverse transcriptase-polymerase chain reaction assays for prostate cancerC A Olsson, G M de Vries, R Buttyan, et al.
Kidney International|June 1, 1989
Gene expression in response to acute unilateral ureteral obstructionI S Sawczuk, G Hoke, C A Olsson, et al.
Seminars in Urologic Oncology|September 19, 1998
The role of tumor biomarkers as predictors of serum PSA recurrence after radical prostatectomyA de la Taille, R Buttyan, M C Benson, et al.
Urology|October 8, 1998
Androgen induction of DNA synthesis in the rat penisR Shabsigh, J F Raymond, C A Olsson, et al.
Molecular and Cellular Biochemistry|December 29, 2000
Regulation of the activity of choline acetyl transferase by lipoic acidN Haugaard, R M Levin
Biochimica Et Biophysica Acta|May 3, 1978
Specificity of the binding of trifluoperazine to the calcium-dependent activator of phosphodiesterase and to a series of other calcium-binding proteinsR M Levin, B Weiss
Cardiovascular Research|March 23, 2000
Adenovirus-encoded hammerhead ribozyme to Bcl-2 inhibits neointimal hyperplasia and induces vascular smooth muscle cell apoptosisH Perlman, M Sata, K Krasinski, et al.
The Prostate|June 9, 2001
Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivoT Dorai, Y C Cao, B Dorai, et al.
Pageof 498